News & Insights

Subscribe

  • People
  • Offices
    • back
    • Offices
    • North America
      • back
      • North America
      • Atlanta
      • Austin
      • Charlotte
      • Chicago
      • Dallas
      • Denver
      • Houston
      • Los Angeles
      • Miami
      • New York
      • Northern Virginia
      • Sacramento
      • San Francisco
      • Silicon Valley
      • Washington, D.C.
    • Europe & Middle East
      • back
      • Europe & Middle East
      • Abu Dhabi
      • Brussels
      • Dubai
      • Frankfurt
      • Geneva
      • London
      • Paris
      • Riyadh
    • Asia
      • back
      • Asia
      • Singapore
      • Tokyo
  • Capabilities
    • back
    • Capabilities
    • Corporate, Finance and Investments
      • back
      • Corporate, Finance and Investments
      • Overview
      • Activist Defense
      • Capital Markets
      • Construction and Procurement
      • Corporate Governance
      • Emerging Companies and Venture Capital
      • Employee Benefits and Executive Compensation
      • Energy and Infrastructure Projects
      • Financial Restructuring
      • Fund Finance
      • Global Human Capital and Compliance
      • Investment Funds and Asset Management
      • Leveraged Finance
      • Mergers and Acquisitions (M&A)
      • Middle East and Islamic Finance and Investment
      • Private Equity
      • Public Companies
      • Real Estate
      • Structured Finance and Securitization
      • Tax
      • Technology Transactions
    • Government Matters
      • back
      • Government Matters
      • Overview
      • Antitrust
      • Data, Privacy and Security
      • Environmental, Health and Safety
      • FDA and Life Sciences
      • Government Advocacy and Public Policy
      • Government Contracts
      • Healthcare
      • Innovation Protection
      • International Trade
      • National Security and Corporate Espionage
      • Securities Enforcement and Regulation
      • Special Matters and Government Investigations
    • Trial and Global Disputes
      • back
      • Trial and Global Disputes
      • Overview
      • Antitrust
      • Appellate, Constitutional and Administrative Law
      • Bankruptcy and Insolvency Litigation
      • Class Action Defense
      • Commercial Litigation
      • Construction and Engineering Disputes
      • Corporate and Securities Litigation
      • E-Discovery
      • Innovation Protection
      • Intellectual Property
      • International Arbitration and Litigation
      • Labor and Employment
      • Product Liability
      • Professional Liability
      • Toxic & Environmental Torts
    • Industries / Issues
      • back
      • Industries / Issues
      • Industries
      • Automotive, Transportation and Mobility
      • Energy Transition
      • Energy
      • Financial Services
      • Food and Beverage
      • Higher Education
      • Life Sciences and Healthcare
      • Technology
      • Issues
      • Artificial Intelligence (AI) and Machine Learning
      • Buy American
      • Crisis Management
      • Doing Business in Latin America
      • Environmental Agenda
      • Environmental, Social and Governance (ESG)
      • Focus on Women's Health
      • Russia/Ukraine
      • Special Purpose Acquisition Companies (SPACs)
  • Careers
    • back
    • Careers
    • Lawyers
      • back
      • Lawyers
      • Experienced Lawyers
    • Students
      • back
      • Students
      • Law Students
      • UK Graduate Recruitment
    • Judicial Clerks
      • back
      • Judicial Clerks
      • Judicial Clerks
    • Business Professionals
      • back
      • Business Professionals
      • Business Professionals
  • News & Insights
    • back
    • News & Insights
    • News
      • back
      • News
      • All News
      • Cases & Deals
      • In the News
      • Press Releases
      • Recognitions
    • Events
      • back
      • Events
      • All Events
      • Conferences
      • Speaking Engagements
      • Webinars
    • Insights
      • back
      • Insights
      • All Insights
      • Newsletters
      • Client Alerts
      • Thought Leadership
      • Articles
      • Feature
      • BLOGS
      • Auditor Liability Bulletin
      • ESG Excellence
  • About
    • back
    • About
    • Our Firm
      • back
      • Our Firm
      • History
      • Our Values
    • Our Culture
      • back
      • Our Culture
      • Overview
    • Citizenship
      • back
      • Citizenship
      • Overview
      • Pro Bono
      • Community Focus
  • Languages

News & Insights

  • News
    • back
    • News
    • All News
    • Cases & Deals
    • In the News
    • Press Releases
    • Recognitions
  • Events
    • back
    • Events
    • All Events
    • Conferences
    • Speaking Engagements
    • Webinars
  • Insights
    • back
    • Insights
    • All Insights
    • Newsletters
    • Client Alerts
    • Thought Leadership
    • Articles
    • Feature
    • BLOGS
    • Auditor Liability Bulletin
    • ESG Excellence

Insights 289 results

Article

Juni 12, 2025
5 Open Questions About FDA's AI-Assisted Review Plans

Client Alert

Juni 5, 2025
Administrative, Congressional, and State Interest Signal a Potential Breakthrough Moment for Psychedelics

Client Alert

Juni 4, 2025
FDA Issues Two Guidances For the Device Q-Sub Process

Newsletter

Juni 2, 2025
Health Headlines – June 2, 2025

Newsletter

Mai 27, 2025
Health Headlines – May 27, 2025

Client Alert

Mai 19, 2025
FDA Announces Completion of AI-Assisted Scientific Review Pilot and Deployment of Agency-Wide AI-Assisted Review

Newsletter

Mai 19, 2025
Health Headlines – May 19, 2025

Client Alert

Mai 9, 2025
New Executive Order Promotes Domestic Production of Critical Medicines

Client Alert

Mai 8, 2025
New Federal Court Decision Holds Proposition 65 Warnings Are Not Required Where There Was No Scientific Consensus on the Carcinogenicity of the Chemical in the Product

Newsletter

Mai 5, 2025
Health Headlines – May 5, 2025

Article

Mai 1, 2025
FDA Releases Draft Guidance on Submission Recommendations for AI-Enabled Device Software Functions

Newsletter

April 28, 2025
Health Headlines – April 28, 2025

© 2025 King & Spalding LLP
  • Contact Us
  • Disclaimer
  • Privacy Notice
  • Transparency Disclosure
  • Cookie Policy
  • Copyright Notice
  • Regulatory Notices
  • Fraud Notice
  • Lawyers Alumni Group